Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap | 13.31M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -14.54M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -20.00% |
Sales | -7.53M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -55.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -84.00% |
Recommedations | - | Quick Ratio | 0.03 | Shares Outstanding | 15.98M | 52W Low Chg | 12.00% |
Insider Own | 38.48% | ROA | -33.19% | Shares Float | 10.34M | Beta | 0.31 |
Inst Own | 1.59% | ROE | -128.85% | Shares Shorted/Prior | 300.71K/2.55M | Price | 1.30 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 58,824 | Target Price | - |
Oper. Margin | 103,749.17% | Earnings Date | Aug 19 | Volume | 36,163 | Change | -6.47% |
About Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights. The company was founded in 2016 and is headquartered in Freehold, New Jersey.
Avalon GloboCare Corp. News